Notizia

The U.S. trade deficit surged to a record high in March, confirming that trade weighed on the economy in the first quarter and could remain a drag for a while as businesses replenish inventories with imported goods.

Wage growth in Europe is still barely visible but underlying pressures are intense and the European Central Bank may already have left it too late to stop strong income growth from seeping into record-high inflation.

Nepal should engage in monetary tightening including rate hikes to contain dwindling forex reserves, without resorting to import curbs that could push up prices and hamper economic growth, a senior International Monetary Fund (IMF) official said.

PARIS (Reuters) -Airbus is delaying development of its A321XLR jet by several months, pushing its arrival to 2024, as regulators tighten the rules to prevent fire risks, industry sources said. The latest upgrade to the best-selling A321 had been due to enter service in late 2023, but the delay stems from discussions with regulators about certification of a novel fuel tank needed to boost its range in a battle for sales with Boeing. The European Union Aviation Safety Agency (EASA) is lookin

BERLIN (Reuters) -German automotive supplier Bosch is aiming to be profitable this year but said that a definitive forecast is not possible due to economic and political uncertainties.

Markets stuck to tight ranges on Wednesday during the final countdown to a widely-expected hike in Federal Reserve interest rates, with outlier crude oil jumping on the prospect of a European oil embargo on Russia.

STOCKHOLM (Reuters) -Security services group Securitas reported on Wednesday a rise in first-quarter profit that matched expectations helped by strong sales growth in Europe.

(Reuters) -Moderna Inc on Wednesday posted nearly $6 billion in sales of its COVID-19 vaccine in the first quarter, and said it expects sales to be higher in the second half of the year than in the first six months.

Moderna Inc on Wednesday maintained the full-year sales forecast for its COVID-19 vaccine at $21 billion, as cases fall and demand slackens after countries rushed to secure shots last year.